| Julie A Haugen, MD | |
|
10 Coburg Rd, Ste 100, Eugene, OR 97401-7479 | |
| (541) 342-8616 | |
| (541) 686-4814 |
| Full Name | Julie A Haugen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 10 Coburg Rd, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508955998 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Care Pc | 8820986458 | 32 |
News Archive
Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public about the unfair labor conditions that they endure that could potentially put Philadelphia's blood supply at risk. More than 100 employees went on strike and set up a picket line yesterday when their issues were ignored by their employer.
As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.
New research in monkeys exposed to SIV, the monkey equivalent of HIV, suggests that the virus spreads rapidly in the body and triggers early host responses that suppress antiviral immunity, thus promoting viral replication.
Fireworks sales will be blazing across the country from now through the Fourth of July. As retailers begin their promotions, the Pennsylvania Academy of Ophthalmology, the Pennsylvania College of Emergency Physicians, and the Pennsylvania Medical Society join the American Academy of Ophthalmology in shining light on the explosive fact: fireworks injuries cause approximately 10,000 visits to the emergency room each year, according to the data from the U.S. Consumer Product Safety Commission.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
› Verified 6 days ago
| Entity Name | Womens Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250044 PECOS PAC ID: 8820986458 Enrollment ID: O20040305001026 |
News Archive
Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public about the unfair labor conditions that they endure that could potentially put Philadelphia's blood supply at risk. More than 100 employees went on strike and set up a picket line yesterday when their issues were ignored by their employer.
As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.
New research in monkeys exposed to SIV, the monkey equivalent of HIV, suggests that the virus spreads rapidly in the body and triggers early host responses that suppress antiviral immunity, thus promoting viral replication.
Fireworks sales will be blazing across the country from now through the Fourth of July. As retailers begin their promotions, the Pennsylvania Academy of Ophthalmology, the Pennsylvania College of Emergency Physicians, and the Pennsylvania Medical Society join the American Academy of Ophthalmology in shining light on the explosive fact: fireworks injuries cause approximately 10,000 visits to the emergency room each year, according to the data from the U.S. Consumer Product Safety Commission.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
› Verified 6 days ago
| Entity Name | Pacific Women's Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669561189 PECOS PAC ID: 0749252898 Enrollment ID: O20040809001380 |
News Archive
Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public about the unfair labor conditions that they endure that could potentially put Philadelphia's blood supply at risk. More than 100 employees went on strike and set up a picket line yesterday when their issues were ignored by their employer.
As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.
New research in monkeys exposed to SIV, the monkey equivalent of HIV, suggests that the virus spreads rapidly in the body and triggers early host responses that suppress antiviral immunity, thus promoting viral replication.
Fireworks sales will be blazing across the country from now through the Fourth of July. As retailers begin their promotions, the Pennsylvania Academy of Ophthalmology, the Pennsylvania College of Emergency Physicians, and the Pennsylvania Medical Society join the American Academy of Ophthalmology in shining light on the explosive fact: fireworks injuries cause approximately 10,000 visits to the emergency room each year, according to the data from the U.S. Consumer Product Safety Commission.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julie A Haugen, MD 10 Coburg Rd, Ste 100, Eugene, OR 97401-7479 Ph: (541) 342-8616 | Julie A Haugen, MD 10 Coburg Rd, Ste 100, Eugene, OR 97401-7479 Ph: (541) 342-8616 |
News Archive
Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public about the unfair labor conditions that they endure that could potentially put Philadelphia's blood supply at risk. More than 100 employees went on strike and set up a picket line yesterday when their issues were ignored by their employer.
As global health leaders struggle to meet the United Nations goal of reducing mortality among the world's poorest children, vaccines are attracting more and more attention. The purchase of the vaccine is just the beginning, however, as the effectiveness of a vaccine is only as good as its delivery system.
New research in monkeys exposed to SIV, the monkey equivalent of HIV, suggests that the virus spreads rapidly in the body and triggers early host responses that suppress antiviral immunity, thus promoting viral replication.
Fireworks sales will be blazing across the country from now through the Fourth of July. As retailers begin their promotions, the Pennsylvania Academy of Ophthalmology, the Pennsylvania College of Emergency Physicians, and the Pennsylvania Medical Society join the American Academy of Ophthalmology in shining light on the explosive fact: fireworks injuries cause approximately 10,000 visits to the emergency room each year, according to the data from the U.S. Consumer Product Safety Commission.
Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer. These studies are part of Isis' broad Phase 2 development program designed to evaluate ISIS-EIF4ERx in multiple types of cancer. ISIS-EIF4ERx targets eukaryotic initiation factor-4E (eIF-4E), a traditionally "undruggable" target that is thought to promote tumor growth and metastasis in many cancers.
› Verified 6 days ago
John York, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 590 Country Club Pkwy, Suite B, Eugene, OR 97401 Phone: 541-686-2922 Fax: 541-683-1709 | |
Katria Laurel Mertz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way, Suite 220, Eugene, OR 97401 Phone: 541-686-7007 Fax: 541-726-5028 | |
Dr. Audrey Paige Garrett, M.D. , MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 520 Country Club Pkwy, Eugene, OR 97401 Phone: 541-683-5001 Fax: 541-683-1422 | |
Tamara A Stenshoel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 Coburg Rd, Ste 100, Eugene, OR 97401 Phone: 541-342-8616 Fax: 541-686-4814 | |
Dr. Brant L. Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Country Club Pkwy, Ste. B, Eugene, OR 97401 Phone: 541-485-2777 Fax: 541-246-2353 | |
Dr. Martha M Reilly, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 S Garden Way, Suite 220, Eugene, OR 97401 Phone: 541-686-7007 Fax: 541-726-5028 | |
Heather Lynne York, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Country Club Pkwy, Ste B, Eugene, OR 97401 Phone: 541-485-2777 Fax: 541-246-2353 |